We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
FMC Corp (FMC) Earnings and Revenues Surpass Estimates in Q1
Read MoreHide Full Article
FMC Corporation (FMC - Free Report) recorded earnings (as reported) of $1.40 per share in first-quarter 2021, down from $1.58 reported a year ago.
Barring one-time items, adjusted earnings per share were $1.53, beating the Zacks Consensus Estimate of $1.52.
Revenues were $1,195.6 million for the quarter, down 4% from the year-ago quarter. It, however, surpassed the Zacks Consensus Estimate of $1,170.3 million.
The decline in revenues was due to 4% lower volumes and 1% pricing headwind, partly offset by 1% favorable impact of currencies. The company saw lower sales across EMEA (Europe, Middle East, and Africa), North America and Latin America, partly offset by gains in Asia.
Sales dropped 8% year over year in North America in the quarter as a shift of diamide third-party partner sales from North America to Latin America more than offset higher sales for herbicides and a strong launch of Xyway fungicide.
Sales in Latin America slipped 22% year over year in the reported quarter due to currency headwinds, lower cotton planting and the company’s channel inventory management.
In EMEA, sales fell 4% year over year, partly due to discontinued registrations. The company witnessed higher insecticide sales in the quarter.
Revenues climbed 18% year over year in Asia on the back of strong demand for Overwatch herbicide in Australia and higher diamide demand in the region.
Financials
The company had cash and cash equivalents of $416.7 million at the end of the quarter, down roughly 4% year over year. Long-term debt was $2,631.4 million, down around 25% year over year.
The company repurchased shares worth $75 million in the first quarter.
Guidance
For 2021, FMC continues to expect revenues to be between $4.9 billion and $5.1 billion, indicating a rise of 8% at the midpoint versus 2020. The growth is expected to be driven mainly by volumes and price increases.
Moreover, FMC envisions adjusted EBITDA of $1.32-$1.42 billion for 2021, indicating a 10% rise at the midpoint versus 2020.
The company has raised its adjusted earnings per share forecast for 2021 to the range of $6.70-$7.40 (up from $6.65-$7.35 expected earlier), reflecting an increase of 14% at the midpoint compared with 2020.
Free cash flow for 2021 is projected to be $530-$620 million, indicating a 6% year-over-year increase.
The company also expects to buyback $400-$500 million shares in 2021.
For second-quarter 2021, revenues are projected in the band of $1.19-$1.26 billion, reflecting an increase of 6% at the midpoint compared with the prior-year quarter. Adjusted earnings are forecast in the range of $1.68-$1.88 per share, representing an increase of 3% at the midpoint compared with the prior-year quarter.
Price Performance
FMC’s shares are up 32.5% over a year against the industry’s 78.4% rise.
Zacks Rank & Key Picks
FMC currently carries a Zacks Rank #3 (Hold).
Better-ranked stocks worth considering in the basic materials space include Nucor Corporation (NUE - Free Report) , Dow Inc. (DOW - Free Report) and Impala Platinum Holdings Limited (IMPUY - Free Report) .
Nucor has a projected earnings growth rate of 228.4% for the current year. The company’s shares have rallied around 129% in a year. It currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Dow has a projected earnings growth rate of 261.5% for the current year. The company’s shares have shot up around 113% in a year. It currently sports a Zacks Rank #1.
Impala Platinum has an expected earnings growth rate of 197.6% for the current fiscal. The company’s shares have surged around 233% in the past year. It currently carries a Zacks Rank #1.
Zacks Top 10 Stocks for 2021
In addition to the stocks discussed above, would you like to know about our 10 best buy-and-hold tickers for the entirety of 2021?
Last year's 2020 Zacks Top 10 Stocks portfolio returned gains as high as +386.8%. Now a brand-new portfolio has been handpicked from over 4,000 companies covered by the Zacks Rank. Don’t miss your chance to get in on these long-term buys.
Image: Bigstock
FMC Corp (FMC) Earnings and Revenues Surpass Estimates in Q1
FMC Corporation (FMC - Free Report) recorded earnings (as reported) of $1.40 per share in first-quarter 2021, down from $1.58 reported a year ago.
Barring one-time items, adjusted earnings per share were $1.53, beating the Zacks Consensus Estimate of $1.52.
Revenues were $1,195.6 million for the quarter, down 4% from the year-ago quarter. It, however, surpassed the Zacks Consensus Estimate of $1,170.3 million.
The decline in revenues was due to 4% lower volumes and 1% pricing headwind, partly offset by 1% favorable impact of currencies. The company saw lower sales across EMEA (Europe, Middle East, and Africa), North America and Latin America, partly offset by gains in Asia.
FMC Corporation Price, Consensus and EPS Surprise
FMC Corporation price-consensus-eps-surprise-chart | FMC Corporation Quote
Regional Sales Performance
Sales dropped 8% year over year in North America in the quarter as a shift of diamide third-party partner sales from North America to Latin America more than offset higher sales for herbicides and a strong launch of Xyway fungicide.
Sales in Latin America slipped 22% year over year in the reported quarter due to currency headwinds, lower cotton planting and the company’s channel inventory management.
In EMEA, sales fell 4% year over year, partly due to discontinued registrations. The company witnessed higher insecticide sales in the quarter.
Revenues climbed 18% year over year in Asia on the back of strong demand for Overwatch herbicide in Australia and higher diamide demand in the region.
Financials
The company had cash and cash equivalents of $416.7 million at the end of the quarter, down roughly 4% year over year. Long-term debt was $2,631.4 million, down around 25% year over year.
The company repurchased shares worth $75 million in the first quarter.
Guidance
For 2021, FMC continues to expect revenues to be between $4.9 billion and $5.1 billion, indicating a rise of 8% at the midpoint versus 2020. The growth is expected to be driven mainly by volumes and price increases.
Moreover, FMC envisions adjusted EBITDA of $1.32-$1.42 billion for 2021, indicating a 10% rise at the midpoint versus 2020.
The company has raised its adjusted earnings per share forecast for 2021 to the range of $6.70-$7.40 (up from $6.65-$7.35 expected earlier), reflecting an increase of 14% at the midpoint compared with 2020.
Free cash flow for 2021 is projected to be $530-$620 million, indicating a 6% year-over-year increase.
The company also expects to buyback $400-$500 million shares in 2021.
For second-quarter 2021, revenues are projected in the band of $1.19-$1.26 billion, reflecting an increase of 6% at the midpoint compared with the prior-year quarter. Adjusted earnings are forecast in the range of $1.68-$1.88 per share, representing an increase of 3% at the midpoint compared with the prior-year quarter.
Price Performance
FMC’s shares are up 32.5% over a year against the industry’s 78.4% rise.
Zacks Rank & Key Picks
FMC currently carries a Zacks Rank #3 (Hold).
Better-ranked stocks worth considering in the basic materials space include Nucor Corporation (NUE - Free Report) , Dow Inc. (DOW - Free Report) and Impala Platinum Holdings Limited (IMPUY - Free Report) .
Nucor has a projected earnings growth rate of 228.4% for the current year. The company’s shares have rallied around 129% in a year. It currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Dow has a projected earnings growth rate of 261.5% for the current year. The company’s shares have shot up around 113% in a year. It currently sports a Zacks Rank #1.
Impala Platinum has an expected earnings growth rate of 197.6% for the current fiscal. The company’s shares have surged around 233% in the past year. It currently carries a Zacks Rank #1.
Zacks Top 10 Stocks for 2021
In addition to the stocks discussed above, would you like to know about our 10 best buy-and-hold tickers for the entirety of 2021?
Last year's 2020 Zacks Top 10 Stocks portfolio returned gains as high as +386.8%. Now a brand-new portfolio has been handpicked from over 4,000 companies covered by the Zacks Rank. Don’t miss your chance to get in on these long-term buys.
Access Zacks Top 10 Stocks for 2021 today >>